Michael Ryskin
BofA Securities, Research Division

We're going to check off day 2 of the BofA Vegas Healthcare Conference. My name is Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team. And I'm excited to be joined by Shawn Vadala, Chief Financial Officer of Mettler-Toledo.

Shawn, great to have you.

Shawn Vadala
Chief Financial Officer

Hey, great to be here, Mike. Thanks for having us.

Michael Ryskin
BofA Securities, Research Division

Always a pleasure. Format will be a fireside chat. If anyone in the audience has a burning question, don't hesitate to raise your hand and we'll throw you in.

Shawn, maybe just to kick things off, you reported 1Q results just a couple of days ago, it feels like in a lifetime, but I think it's a little bit 3 or 4 days. A lot of moving pieces in the quarter. A lot of debate on how it played out relative to expectations and sort of like what the moving pieces are. Maybe you could just start there and run us through high level what happened relative to your expectations or how it impacts your view going forward?

Shawn Vadala
Chief Financial Officer

Yes, sure. So maybe a few comments. The first thing I don't want to get lost in the quarter is that we felt really good about our earnings growth in the quarter. We had very strong earnings growth, 9% growth. And I think a more difficult environment. And I think that really comes back to not only execution but really says a lot about the culture and the agility of the